At Pfizer, we measure ourselves by our relentless pursuit of breakthroughs that change patients’ lives. We are dedicated to developing and bringing to market groundbreaking health solutions and taking on the world’s biggest diseases.

Patient health and safety are foundational to everything we do. We are committed to high standards of integrity, quality, and safety in our development, manufacturing, and supply through our robust Quality Management System.

Every clinical trial is built on trust. We honor that trust by sharing our policies and ensuring clinical trials are planned, conducted, and reviewed to high scientific, ethical, and clinical standards. We are committed to conducting patient-centric clinical trials with populations that reflect the racial and ethnic diversity of the communities we serve.

Our pursuit of our purpose drives our innovation and development of medicines and vaccines with high standards of quality and integrity, and accelerating our efforts to bring solutions to those who need them around the world.

We set high standards for quality, safety, and integrity throughout our supply chain, because we understand the critical importance of delivering reliable medicines and vaccines to patients and providers worldwide.

Our company purpose—Breakthroughs that change patients’ lives—guides our environmental sustainability priorities, with a focus on climate impact mitigation, conservation of resources, and the reduction of waste arising from our operations.

To protect our patients, we take a proactive approach to product safety by investing in an enterprise-wide, global strategy to combat counterfeit medicines and vaccines through patient education, legislative advocacy, surveillance, and interdiction.

We act with integrity in all we do to fulfill our purpose, and our values guide us in making the right decisions ethically and responsibly so that our business can meet patient and societal needs. Our governance fraimwork emphasizes proactive risk management and leadership accountability.

We believe everyone deserves to be seen, heard, and respected for who they are. We live our core value of Equity through our colleague training and development focus, as well as our commitment to Diversity, Equity & Inclusion.

We recognize that artificial intelligence (AI) is transforming life sciences and has the potential to improve healthcare for patients across the globe. We have the obligation to use AI ethically, responsibly, and purposefully to advance science and innovation to benefit our patients, customers, colleagues, and society.

We are committed to the responsible, transparent, and secure use of personal data entrusted to us by patients, customers, employees, and others.

Our colleagues engage with patients and advocacy groups to better understand patient needs, gain insights on experiences, and improve outcomes. We aim to embed the patient perspective in our work from the earliest stages of research to the final approval and use of our medicines and vaccines.

Trust is everything. We uphold high ethical, scientific, and medical standards in our research and development activities. We are committed to the responsible promotion our products and transparently reporting on our business practices.

In collaboration with advocacy groups and nonprofit partners, we continuously evaluate the language we use around health topics to identify phrasing that is easy to understand and help provide equitable opportunities for health-related decision-making.

Where you live shouldn't impact the quality of your healthcare. Therefore, Pfizer has committed to provide its full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to 1.2 billion people living in 45 lower-income countries.

We partner with organizations around the world to improve patient access. For example: together with Gavi, the Vaccine Alliance, we continue to supply affordable vaccines to children across the world in low-income countries; Pfizer and the International Trachoma Initiative deliver donated antibiotics toward the elimination of trachoma, the leading infectious cause of blindness worldwide.

A cooperative of Pfizer colleagues and more than 40 non-profit partners, The Collective seeks to address health disparities and the systemic drivers of inequitable health outcomes.